People · Operator
Named in public records as an officer, director or promoter · active 2019–2022 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Titan Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $15.5M | $23.0M | 2019 |
M. David McFarlane at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside M. David McFarlane on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott A. Smith | 1 | 8 |
| Marc Rubin | 1 | 6 |
| James R. McNab, Jr. | 1 | 3 |
| Sunil Bhonsle | 1 | 1 |
| Katherine DeVarney | 1 | 1 |
| Dane Hallberg | 1 | 1 |
| Rajinder A. Kumar | 1 | 1 |
| Katherine Beebe | 1 | 1 |
| Katherine Beebe DeVarney | 1 | 1 |
| Joseph A. Akers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.